WCDO2024

Conference Introduction

We are so proud to announce that the 8th World Congress of Diabetes & Obesity(WCDO) will be held on September 12-14, 2024 in the beautiful city of Shanghai, China. The World Congress of Diabetes & Obesity has been successfully organized seven times. With a focus on disease prevention, treatment methods, emerging research, and health management, the conference program is carefully curated to provide a comprehensive and diverse range of topics. Through keynote speeches, panel discussions, seminars, and poster presentations, attendees will have the opportunity to delve into cutting-edge research, explore innovative approaches, and engage in thought-provoking discussions.
This congress serves as a catalyst for collaboration, innovation, and progress in addressing the global challenges posed by these pressing health issues.

Highlights

● One Plenary Forum Addressed by a Panel of Prominent Leaders
● Parallel Meetings in the Field of Biomedicine
● 20+ High-Profile Breakout Sessions across 3-Days Conference
● 100+ Oral Presentations Covering Hot Topics and Cutting-Edge Technology
● 300+ Attendees from Across the Globe for Unrivaled Network in Building up a High-end International Conference Brand, Promoting Scientific Exchanges, Cooperative Development, and Establishing a Marketing platform
● Tech Tour to Famous Spots

Confirmed Distinguished Speakers

Dr. Mark Bradley, Chair and Centre Lead, Queen Mary University of London, UK	Dr. Renfeng Guo, CSO, Inflarx Pharmaceutical Inc., USA	Dr. Jens Erik Nielsen, Vice President, Enzyme Research, Novozymes A/S, Denmark
Dr. Thomas Wittlinger, Professor, Goslar Hospital, Germany	Dr. Muxiang Zhou, Professor, Emory University School of Medicine, USA	Dr. Frank Yu Wang, Professor of Chemistry, University of North Carolina, USA
Dr. Da Zhi Liu, Professor, University of California at Davis; Founder, Mirnova Therapeutics, Inc., USA	Dr. Guang Sun, Professor, Memorial University of Newfoundland, Canada	Dr. Horacio N. Pappa, Senior Director, Global Science and Standards Division, United States Pharmacopeia, USA
Dr. Franklin Wong, Professor, The University of Texas M. D. Anderson Cancer Center, USA	Dr. Michael Castagna, Chief Executive Officer, MannKind Corporation, USA	Dr. Jasmina Novakovic, Principal Scientist, Simulations Plus, Inc., USA
Dr. Bernat Kocsis, Associate Professor, Beth Israel Deaconess Medical Center, USA	Dr. Chuanxi Cai, Associate Professor, Albany Medical College, USA	Dr. Maliha Zahid, Associate Professor, Mayo Clinic, USA
Dr. Aneta Nitsch-Osuch, Professor, Medical University of Warsaw, Poland	Dr. Alexander Tuzikov, Professor, National Academy of Sciences of Belarus, Belarus	Dr. Xiaojian Yao, Director, Laboratory of Molecular Human Retrovirology, University of Manitoba, Canada
Dr. Ruola Ning, Professor, University of Rochester, USA	Dr. Maliha Zahid, Associate Professor, Mayo Clinic, USA	Dr. Zhangguo Chen, Research Associate Professor, University of Pittsburgh, USA
Dr. Keun-Hwa Lee, Professor, Hanyang University, South Korea	Dr. Chongyang Liang, Professor, School of Pharmaceutical Sciences, Jilin University, China	Dr. Jing H Wang, Associate Professor, University of Pittsburgh, USA
Dr. Haoran Yu, Principal Investigator, College of Chemical and Biological Engineering, Zhejiang University, China	Dr. Cheng Chi-Feng, Professor, Department of Oncology, Taipei City United Hospital, Taiwan	Dr. Khalid Asadi, The University of Auckland, New Zealand
Dr. Bing Li, Associate Professor, Department of Microbiology and Immunology, University of Louisville, USA	Dr. Phoency F.-H. Lai, Professor, University of Shanghai for Science and Technology, China	Dr. Oleg Kshivets, Head of Surgery Department, Bagrationovsk Hospital, Kaliningrad Oblast, Russia
Dr. Danyun Zeng, Associate Researcher, Innovation Academy for Precision Measurement Science and Technology, CAS, China	Dr. Catalin Mihalcioiu, Assistant Professor, University of Montreal Research Center (CRCHUM), Canada	Dr. Yu-Xiang Fang, Associated Investigator, Shanghai Jiao Tong University, China
Dr. Silvia Gartner, Pediatric Pulmonology and Cystic Fibrosis Unit, Hospital Universitari Vall d'Hebron, Spain	Dr. Xiaolei Zhu, Assistant Professor, Johns Hopkins University, USA	Dr. Rana Al Awadhi, Associate Professor, Kuwait University, Kuwait

Program Layout at a Glance

Part 1: Opening Ceremony and Keynote Forum Agenda
Part 2: Parallel Forums
Stream 1: New Horizons of Diabetes of Obesity Science and Technologies
Stream 2: Clinical Science and Practice of Diabetes and Obesity
Stream 3: Anti-Diabetes and Anti-Obesity Drug Discovery
Stream 4: TCM and Nutraceuticals in Diabetes and Obesity
Part 3: Poster and Exhibition
Part 4: Social Activity and Cultural Events

Exhibition and Poster

WCDO-2024 provides an ideal platform to showcase your novel technologies and products. It is developed to offer comfort to delegates while maximizing exhibitor exposure, the poster sessions will also take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits.

Conference City Introduction

Shanghai, often referred to as the "Pearl of the Orient," is a vibrant and cosmopolitan city in China. Known for its iconic skyline, Shanghai boasts a stunning array of towering skyscrapers, including the Oriental Pearl Tower and the Jin Mao Tower. The city's impressive architecture reflects its status as a global financial hub and a center for international trade. Its modern infrastructure, efficient transportation system, and world-class facilities make Shanghai an attractive destination for conferences and events.
Shanghai combines the best of both worlds—a modern metropolis with a rich cultural heritage. Its unique blend of East and West, coupled with its world-class facilities and vibrant atmosphere, makes Shanghai an ideal location for the 8th World Congress of Diabetes & Obesity.